MC
CRL icon

Machina Capital’s Charles River Laboratories CRL Stock Holding History

Machina Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-505
Closed -$72K – 350
2019
Q2 		$72K Buy
+505
New +$68.5K 0.03% 383

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Machina Capital's CRL Position: Q3 2019 in Review

Machina Capital sold out of Charles River Laboratories (CRL) in Q3 2019, closing a stake of 505 shares — an estimated $72K sold.

Machina Capital first reported a position in CRL in Q2 2019 and held it in 1 quarter. The position peaked at $72K in Q2 2019. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

  • Machina Capital reported no remaining Charles River Laboratories position as of Q3 2019 after selling out during the quarter.
  • Machina Capital sold 505 Charles River Laboratories shares in Q3 2019, an estimated $72K.
  • Machina Capital first reported a position in Charles River Laboratories in Q2 2019 and held it in 1 quarter.
  • Machina Capital's Charles River Laboratories position peaked at $72K in Q2 2019.
  • 396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Machina Capital's 13F filing for Q3 2019, filed 12 Nov 2019.